Eagle Seeds And Biotech Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 09-11-2024
- Paid Up Capital ₹ 2.99 Cr
as on 09-11-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 160.00 Cr
as on 09-11-2024
- Satisfied Charges ₹ 50.74 Cr
as on 09-11-2024
- Revenue 40.32%
(FY 2023)
- Profit -52.70%
(FY 2023)
- Ebitda -55.94%
(FY 2023)
- Net Worth 10.38%
(FY 2023)
- Total Assets -3.98%
(FY 2023)
About Eagle Seeds And Biotech
The Corporate was formerly known as Eagle Seeds And Agritech Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 2.99 Cr.
The company currently has active open charges totaling ₹160.00 Cr. The company has closed loans amounting to ₹50.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sumangala Jain, Shirish Barwale, Vaibhav Jain, and Three other members serve as directors at the Company.
- CIN/LLPIN
U01409MP1997PTC011544
- Company No.
011544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 1997
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eagle Seeds And Biotech?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vaibhav Jain | Managing Director | 01-Oct-2005 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shirish Barwale | Director | 16-Jun-2006 | Current |
Ganpati Nadkarni | Director | 22-Oct-2022 | Current |
Ajay Vaidya | Director | 07-Dec-2021 | Current |
Sumangala Jain | Director | 14-Oct-2011 | Current |
Gulab Singhvi | Director | 23-Dec-2014 | Current |
Financial Performance and Corporate Structure Insights of Eagle Seeds And Biotech.
Eagle Seeds And Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.32% increase. The company also saw a substantial fall in profitability, with a 52.7% decrease in profit. The company's net worth Soared by an impressive increase of 10.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Eagle Seeds And Biotech?
In 2023, Eagle Seeds And Biotech had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Snipp Interactive (India) Private LimitedActive 9 years 4 months
Ganpati Nadkarni is a mutual person
- Maharashtra Hybrid Seeds Company Private LimitedActive 54 years 8 months
Shirish Barwale is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 13 Feb 2024 | ₹40.00 Cr | Open |
Hdfc Bank Limited Creation Date: 13 Feb 2024 | ₹80.00 Cr | Open |
Hdfc Bank Limited Creation Date: 14 Jan 2010 | ₹40.00 Cr | Open |
How Many Employees Work at Eagle Seeds And Biotech?
Eagle Seeds And Biotech has a workforce of 236 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eagle Seeds And Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eagle Seeds And Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.